US Patent Issued to The Regents of the University of California on Nov. 3 for "System and method for discovering validating and personalizing transposable element cancer vaccines" (California Inventor)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,782,338, issued on Nov. 3, was assigned to The Regents of the University of California (Oakland, Calif.).

"System and method for discovering validating and personalizing transposable element cancer vaccines" was invented by Jacob Pfeil (Santa Cruz, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Candidate cancer antigens are identified using transposable elements. Differential expression levels are determined for proteins using baseline expression levels (using measurements of healthy tissue) and tumor expression levels (using measurements of tumor tissue). Protein(s) having a differential expression level greater than a threshold are selected. Can...